Sarah Kerns, PhD, assistant professor, department of radiation oncology, University of Rochester Medical Center, Rochester, New York, and coauthor of study titled “Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study” published in Journal of Clinical Oncology.
Chemotherapy cures testicular cancer in most people, but the main drug can stay in your system for over 20 years, causing many other health problems.
